Significant association of XRCC4 single nucleotide polymorphisms with prostate cancer susceptibility in Taiwanese males

Molecular Medicine Reports

Volumn 1, Issue 4, 2008, Pages 525-530

  Chang, Chao Hsiang ^a   Chiu, Chang Fang ^a   Wu, Hsi Chin ^a   Tseng, Hsien Chang ^a   Wang, Chung Hsing ^a   Lin, Cheng Chieh ^a,c   Tsai, Chia Wen ^a,b   Liang, Shiu Yun ^a   Wang, Cheng Li ^a   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

DNA repair; Prostate; Single nucleotide polymorphism; XRCC4

Indexed keywords

XRCC4 PROTEIN;

AGED; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 69249127101     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.4.525     Document Type: Article

References (18)

1. Gronberg H: Prostate cancer epidemiology. Lancet 361: 859-864, 2003.
2. Hsing AW and Chokkalingam AP: Prostate cancer epidemiology. Front Biosci 11: 1388-1413, 2006.
3. Department of Health, Taiwan: Cancer registration system annual report. Department of Health, Taiwan, 2006.
4. Bau DT, Wu HC, Chiu CF, Lin CC, Hsu CM, Wang CL, Wang RF and Tsai FJ: Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res 27: 2893-2896, 2007. (Pubitemid 47228017)
5. Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann Surg Oncol 15: 514-518, 2008.
6. Chiu CF, Tsai MH, Tseng HC, Wang CL, Tsai FJ, Lin CC and Bau DT: A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol (In press).
7. Bau DT, Tsai MH, Lo YL, Hsu CM, Tsai Y, Lee CC and Tsai FJ: Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. Anticancer Res 27: 1559-1564, 2007. (Pubitemid 46807237)
8. Bau DT, Mau YC, Ding SL, Wu PE and Shen CY: DNA double-strand break repair capacity and risk of breast cancer. Carcinogenesis 28: 1726-1730, 2007. (Pubitemid 47289034)
9. Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang CH, Wu CN, Lin CC and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol (In press).
10. Mari PO, Florea BI, Persengiev SP, Verkaik NS, Bruggenwirth HT, Modesti M, Giglia-Mari G, Bezstarosti K, Demmers JA, Luider TM, Houtsmuller AB and van Gent DC: Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc Natl Acad Sci USA 103: 18597-18602, 2006. (Pubitemid 44913456)
11. Van Heemst D, Brugmans L, Verkaik NS and van Gent DC: End-joining of blunt DNA double-strand breaks in mammalian fibroblasts is precise and requires DNA-PK and XRCC4. DNA Repair 3: 43-50, 2004. (Pubitemid 38021994)
12. Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, Chen ST, Wu HS, Wu PE and Shen CY: Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 63: 2440-2446, 2003.
13. Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, Frank KM, Chaudhuri J, Horner J, De Pinho RA and Alt FW: Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404: 897-900, 2000. (Pubitemid 30230344)
14. Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ, Sekiguchi JM, Rathbun GA, Swat W, Wang J, Bronson RT, Malynn BA, Bryans M, Zhu C, Chaudhuri J, Davidson L, Ferrini R, Stamato T, Orkin SH, Greenberg ME and Alt FW: A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95: 891-902, 1998. (Pubitemid 29019042)
15. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK and Cockett AT: The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148: 1549-1557, 1992.
16. Gleason DF and Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111: 58-64, 1974.
17. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J and Crawford LV: Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7: 961-963, 1987. (Pubitemid 17004567)
18. Thomas M, Kalita A, Labrecque S, Pim D, Banks L and Matlashewski G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092-1100, 1999. (Pubitemid 29046852)